Can-Fite Biopharma Ltd - ADR

ASE:CANF  
2.28
-0.05 (-2.15%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)38.35M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.22 Million
Adjusted EPS-$0.11
See more estimates
10-Day MA$2.28
50-Day MA$2.16
200-Day MA$2.03
See more pivots

Can-Fite Biopharma Ltd - ADR Stock, ASE:CANF

10 Bareket Street, Kiryat Matalon, Petach Tikva, HaMerkaz 49170
Israel
Phone: +972.3.924.1114
Number of Employees: 8

Description

Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for cancer and inflammatory diseases. Its product pipeline includes Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.